Study of ONO-1101 in Patients Scheduled for Coronary Angiography

Study of ONO-1101 in Patients Scheduled for Coronary Angiography, a Double-Blind, Randomized,Placebo-Controlled, Parallel Group, Multi-Center Study

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for coronary angiography, in a double-blind, randomized, placebo-controlled, parallel group, multi-center study.

Inclusion Criteria:

• 20 years of age or older
• Heart rate less than 90 beats/min and more than 70 beats/min at entering the CT room

Exclusion Criteria:

• Previous allergic reactions to contrast agent
• Renal failure
• Asthma
• Concomitant beta-receptor blocking agent